Journal
CANCERS
Volume 15, Issue 20, Pages -Publisher
MDPI
DOI: 10.3390/cancers15204977
Keywords
liver cancer; hepatocellular carcinoma; immunotherapy; tumour microenvironment; tumour-associated macrophages; innate immune system; macrophage reprogramming
Categories
Ask authors/readers for more resources
Hepatocellular carcinoma (HCC) is a highly lethal disease with a complex tumour microenvironment (TME). Tumour-associated macrophages (TAMs) play a key role in the development and progression of HCC. Reprogramming TAMs' functional state has emerged as a promising option for immunotherapy. This review focuses on the heterogeneity of TAMs in HCC, the mechanisms behind their pro-tumoural polarization, and the potential of TAMs' reprogramming in HCC therapy.
Simple Summary Hepatocellular carcinoma (HCC) is a highly lethal disease with an increasing incidence. Despite the advancements in diagnosis and recent therapeutic options, improving the prognosis of HCC patients remains challenging. One of the reasons of the unsatisfactory outcome of patients with HCC is the complex tumour microenvironment (TME), which is composed of immune and stromal cells, limiting effective treatments. Recent research has highlighted the importance of macrophages in the development and progression of HCC, opening new possibilities for therapy. This review focuses on the heterogeneity of tumour-associated macrophages (TAMs) in HCC, the mechanisms through which HCC tumour cells polarize macrophages, and the therapeutic targets that are currently being tested to explore novel therapies that can improve the prognosis and quality of life of HCC patients.Abstract Hepatocellular carcinoma (HCC) is a prevalent and aggressive cancer that comprises a complex tumour microenvironment (TME). Tumour-associated macrophages (TAMs) are one of the most abundant immune cells present in the TME, and play a key role both in the development and in the progression of HCC. Thus, TAM-based immunotherapy has been presented as a promising strategy to complement the currently available therapies for HCC treatment. Among the novel approaches focusing on TAMs, reprogramming their functional state has emerged as a promising option for targeting TAMs as an immunotherapy in combination with the currently available treatment options. Nevertheless, a further understanding of the immunobiology of TAMs is still required. This review synthesizes current insights into the heterogeneous nature of TAMs in HCC and describes the mechanisms behind their pro-tumoural polarization focusing the attention on their interaction with HCC cells. Furthermore, this review underscores the potential involvement of TAMs' reprogramming in HCC therapy and highlights the urgency of advancing our understanding of these cells within the dynamic landscape of HCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available